J
Joshua Samuels
Researcher at University of Texas Health Science Center at Houston
Publications - 106
Citations - 5676
Joshua Samuels is an academic researcher from University of Texas Health Science Center at Houston. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 30, co-authored 93 publications receiving 4011 citations. Previous affiliations of Joshua Samuels include University of Texas at Austin & Drexel University.
Papers
More filters
Journal ArticleDOI
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents.
Joseph T. Flynn,David C. Kaelber,Carissa M. Baker-Smith,Douglas L. Blowey,Aaron E. Carroll,Stephen R. Daniels,Sarah D. de Ferranti,Janis M. Dionne,Bonita Falkner,Susan K. Flinn,Samuel S. Gidding,Celeste Goodwin,Michael G. Leu,Makia Powers,Corinna J. Rea,Joshua Samuels,Madeline Simasek,Vidhu V Thaker,Elaine M. Urbina,Subcommittee On Screening +19 more
TL;DR: These pediatric hypertension guidelines are an update to the 2004 report and include revised recommendations on when to perform echocardiography in the evaluation of newly diagnosed hypertensive pediatric patients (generally only before medication initiation), along with a revised definition of left ventricular hypertrophy.
Journal ArticleDOI
Improved Postoperative Outcomes Associated with Preoperative Statin Therapy
Katja Hindler,Andrew D. Shaw,Joshua Samuels,Stephanie Fulton,Charles D. Collard,Bernhard Riedel,Bernhard Riedel +6 more
TL;DR: Preoperative statin therapy may reduce postoperative mortality in patients undergoing surgical procedures, however, the statin associated effects on postoperative cardiovascular morbidity are too variable to draw any conclusion.
Journal ArticleDOI
Masked Hypertension Associates with Left Ventricular Hypertrophy in Children with CKD
Mark Mitsnefes,Joseph T. Flynn,Silvia Cohn,Joshua Samuels,Tom Blydt-Hansen,Jeffrey M. Saland,Thomas R. Kimball,Susan L. Furth,Bradley A. Warady +8 more
TL;DR: It is concluded that casual BP measurements alone are insufficient to predict the presence of LVH in children with CKD and the high prevalence of masked hypertension and its association with LVH supports early echocardiography and ambulatory BP monitoring to evaluate cardiovascular risk in childrenWith CKD.
Journal ArticleDOI
Left Ventricular Hypertrophy in Hypertensive Adolescents Analysis of Risk by 2004 National High Blood Pressure Education Program Working Group Staging Criteria
Karen L. McNiece,Monesha Gupta-Malhotra,Joshua Samuels,Cynthia S. Bell,Kathleen Garcia,Timothy Poffenbarger,Jonathan M. Sorof,Ronald J. Portman +7 more
TL;DR: Recommendations that adolescents with stage 2 HTN by casual measurements alone receive medication initially along with therapeutic lifestyle counseling are reasonable, though ambulatory blood pressure monitoring remains a valuable tool for evaluating children with stage 1 HTN, because >10% have white-coat HTN.
Journal ArticleDOI
Fenoldopam Mesylate in Early Acute Tubular Necrosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
James A. Tumlin,Kevin W. Finkel,Patrick T. Murray,Joshua Samuels,George Cotsonis,Andrew D. Shaw +5 more
TL;DR: Fenoldopam does not reduce the incidence of death or dialysis therapy in intensive care unit patients with early ATN and a larger multicenter trial using separate randomizations for patients with and without diabetes will be needed to determine the efficacy of fenoldo mesylate in specific subpopulations with ATN.